Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Remdesivir was associated with a significant survival benefit and reduced risk for rehospitalization among inpatients with COVID-19 infection.

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

A randomized clinical trial found that low-dose lithium aspartate did not improve cognitive dysfunction or fatigue in long ...

Despite Health Secretary Robert F Kennedy Jr’s announcement ending covid-19 vaccine recommendations for healthy children and pregnant women, the Centers for Disease Control and Prevention (CDC) has ...

Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer ...

Head and neck cancer patients went disease-free for five years, compared to half that time for people undergoing standard ...